vigabatrin and taurine
vigabatrin has been researched along with taurine in 21 studies
Research
Studies (21)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 12 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Meldrum, B | 1 |
| Brady, KT; Malcolm, R; Myrick, H | 1 |
| Bartels, H; Froestl, W; Gibson, KM; Greven, R; Grompe, M; Gupta, M; Hogema, BM; Jakobs, C; Jansen, EE; Snead, OC | 1 |
| Bhakoo, K; Blamire, AM; Dixon, RM; Sibson, NR; Styles, P; Welch, JW | 1 |
| Barghouthi, S; Sulaiman, SA; Suliman, FE | 1 |
| Frosini, M; Gaggelli, N; Machetti, F; Ricci, L; Sgaragli, G; Valensin, G; Valoti, M | 1 |
| Chepkova, AN; Fleischer, W; Haas, HL; Häussinger, D; Sergeeva, OA; Siebler, M; Warskulat, U | 1 |
| Chiron, C; Collins, SD; Coriat, C; Craft, CM; Duboc, A; Dubus, E; Dulac, O; Jammoul, F; Nabbout, R; Picaud, S; Sahel, JA; Simonutti, M; Wang, Q; Ye, W | 1 |
| Caplette, R; Craft, CM; Dégardin, J; Dubus, E; Fouquet, S; Gondouin, P; Jammoul, F; Pain, D; Picaud, S; Sahel, JA; Simonutti, M | 1 |
| Frosini, M; Ricci, L; Sgaragli, G; Valoti, M | 1 |
| Plant, GT; Sergott, RC | 1 |
| Gidal, BE; Heim, MK | 1 |
| Cadetti, L; Degardin, J; Dubus, E; Forster, V; Froger, N; Gaucher, D; Ivkovic, I; Jammoul, F; Lorach, H; Pain, D; Picaud, S; Sahel, JA; Simonutti, M | 1 |
| Hansen, SH; Holm, R; Nielsen, CU; Nøhr, MK; Plum, J | 1 |
| Botteron, C; Pickersgill, N; Rasmussen, AD; Rosolen, SG; Thale, ZI; Truchot, N | 1 |
| Holm, R; Lagunas, C; Nielsen, CU; Plum, J; Rasmussen, RN | 1 |
| Aroichane, M; Horvath, GA; Hukin, J; Stockler-Ipsiroglu, SG | 1 |
| Mabud, TS; Porter, BE; Reimer, R; Spelbrink, EM | 1 |
| Huang, YF; Liu, C; Ma, J; Ma, Z; Tao, Y; Wang, Y; Yan, Z; Yang, J; Yang, Z | 1 |
| Narasimha Murthy, S; Police, A; Shankar, VK | 1 |
Reviews
3 review(s) available for vigabatrin and taurine
| Article | Year |
|---|---|
New developments in the pharmacotherapy of alcohol dependence.
Topics: Acamprosate; Adjuvants, Anesthesia; Alcohol Deterrents; Alcoholism; Anticonvulsants; Buspirone; Carbamazepine; Drug Therapy; Ethanol; Humans; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Ritanserin; Serotonin Agents; Sodium Oxybate; Substance Withdrawal Syndrome; Taurine; Valproic Acid; Vigabatrin | 2001 |
Understanding and interpreting vision safety issues with vigabatrin therapy.
Topics: 4-Aminobutyrate Transaminase; Adult; Animals; Anticonvulsants; Causality; Comorbidity; Confounding Factors, Epidemiologic; Epilepsies, Partial; Female; Humans; Infant; Male; Retina; Retinal Diseases; Spasms, Infantile; Taurine; Vigabatrin; Vision Disorders; Vision Tests; Visual Fields | 2011 |
Vigabatrin-associated retinal damage: potential biochemical mechanisms.
Topics: Animals; Anticonvulsants; Epilepsy; Humans; Retinal Diseases; Taurine; Vigabatrin | 2012 |
Trials
1 trial(s) available for vigabatrin and taurine
| Article | Year |
|---|---|
Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity.
Topics: Amino Acids; Analysis of Variance; Animals; Child, Preschool; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Humans; Indoles; Infant; Mice; Photosensitivity Disorders; Rats; Retina; Retinal Diseases; Statistics as Topic; Taurine; Vigabatrin | 2009 |
Other Studies
17 other study(ies) available for vigabatrin and taurine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
GABAergic agents as anticonvulsants in baboons with photosensitive epilepsy.
Topics: Aminocaproates; Animals; Anticonvulsants; Baclofen; Carbolines; Cerebral Cortex; Dose-Response Relationship, Drug; Epilepsies, Myoclonic; gamma-Aminobutyric Acid; Isoxazoles; Muscimol; Papio; Photic Stimulation; Receptors, Cell Surface; Receptors, GABA-A; Taurine; Vigabatrin | 1984 |
Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria).
Topics: Aldehyde Oxidoreductases; Animals; Benzocycloheptenes; Body Weight; gamma-Aminobutyric Acid; Genotype; Injections, Intraperitoneal; Longevity; Mice; Mice, Inbred C57BL; Mice, Knockout; Organophosphorus Compounds; Phenotype; Sodium Oxybate; Succinate-Semialdehyde Dehydrogenase; Survival; Taste; Taurine; Vigabatrin | 2002 |
In vivo monitoring of rat brain metabolites during vigabatrin treatment using localized 2D-COSY.
Topics: Animals; Brain; gamma-Aminobutyric Acid; Glutamine; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Wistar; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Taurine; Vigabatrin | 2003 |
Kinetic studies on the inhibition of GABA-T by gamma-vinyl GABA and taurine.
Topics: 4-Aminobutyrate Transaminase; Enzyme Inhibitors; Kinetics; Taurine; Vigabatrin | 2003 |
Inhibition of rabbit brain 4-aminobutyrate transaminase by some taurine analogues: a kinetic analysis.
Topics: 4-Aminobutyrate Transaminase; Aminoethylphosphonic Acid; Animals; Anticonvulsants; Brain; Enzyme Inhibitors; Male; Piperidines; Rabbits; Sulfanilic Acids; Taurine; Vigabatrin | 2006 |
GABAA-receptor modification in taurine transporter knockout mice causes striatal disinhibition.
Topics: Animals; Bicuculline; Cells, Cultured; Corpus Striatum; Female; GABA Agents; GABA Antagonists; Inhibitory Postsynaptic Potentials; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Knockout; Neural Inhibition; Receptors, GABA-A; Taurine; Vigabatrin | 2007 |
Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Cell Count; Cell Death; Electroretinography; Fluorescent Antibody Technique; Neuroprotective Agents; Optic Atrophy; Photoreceptor Cells; Rats; Rats, Wistar; Retinal Ganglion Cells; Taurine; Vigabatrin | 2010 |
Taurine-like GABA aminotransferase inhibitors prevent rabbit brain slices against oxygen-glucose deprivation-induced damage.
Topics: 4-Aminobutyrate Transaminase; Animals; Brain; Brain Ischemia; gamma-Aminobutyric Acid; Glucose; Male; Neuroprotective Agents; Oxygen; Rabbits; Reperfusion Injury; Taurine; Tissue Culture Techniques; Vigabatrin | 2012 |
Taurine is a crucial factor to preserve retinal ganglion cell survival.
Topics: Animals; Cell Survival; Disease Models, Animal; Glaucoma; Membrane Glycoproteins; Membrane Transport Proteins; Neuroprotective Agents; Rats; Retinal Ganglion Cells; Retinitis Pigmentosa; Taurine; Time Factors; Vigabatrin | 2013 |
The anti-epileptic drug substance vigabatrin inhibits taurine transport in intestinal and renal cell culture models.
Topics: Animals; Anticonvulsants; Caco-2 Cells; Dogs; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Mucosa; Kidney; Madin Darby Canine Kidney Cells; Taurine; Vigabatrin | 2014 |
The effects of taurine on vigabatrin, high light intensity and mydriasis induced retinal toxicity in the pigmented rat.
Topics: Animals; Anticonvulsants; Atropine; Disease Models, Animal; Electroretinography; Male; Mydriasis; Mydriatics; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Retina; Taurine; Vigabatrin | 2015 |
Interaction of GABA-mimetics with the taurine transporter (TauT, Slc6a6) in hyperosmotic treated Caco-2, LLC-PK1 and rat renal SKPT cells.
Topics: Aminolevulinic Acid; Animals; beta-Alanine; Caco-2 Cells; Cell Line; gamma-Aminobutyric Acid; Humans; Isoxazoles; Kidney; LLC-PK1 Cells; Membrane Glycoproteins; Membrane Transport Proteins; Nicotinic Acids; Nipecotic Acids; Osmolar Concentration; Osmosis; Proline; Rats; RNA, Messenger; Swine; Taurine; Vigabatrin | 2016 |
Eye Findings on Vigabatrin and Taurine Treatment in Two Patients with Succinic Semialdehyde Dehydrogenase Deficiency.
Topics: Amino Acid Metabolism, Inborn Errors; Anticonvulsants; Child; Developmental Disabilities; Electroretinography; Female; Humans; Male; Retinal Dystrophies; Succinate-Semialdehyde Dehydrogenase; Taurine; Vigabatrin | 2016 |
Plasma taurine levels are not affected by vigabatrin in pediatric patients.
Topics: Age Factors; Analysis of Variance; Anticonvulsants; Child, Preschool; Cohort Studies; Epilepsy; Female; Humans; Male; Taurine; Vigabatrin | 2016 |
The Vigabatrin Induced Retinal Toxicity is Associated with Photopic Exposure and Taurine Deficiency: An In Vivo Study.
Topics: Animals; Electroretinography; Light; Mice, Inbred C57BL; Retina; Taurine; Time Factors; Tomography, Optical Coherence; Vigabatrin; Visual Acuity | 2016 |
RP-HPLC method for simultaneous estimation of vigabatrin, gamma-aminobutyric acid and taurine in biological samples.
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; gamma-Aminobutyric Acid; Humans; Linear Models; Male; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Retina; Sensitivity and Specificity; Taurine; Vigabatrin | 2018 |